Medical professionals performing surgery in an operating room.
Our Work

Latham Advises on Kangji Medical Proposed Privatization

August 18, 2025
Hong Kong team represents Kangji Medical founder and chairman Mr. Zhong Ming in the transaction.

Latham & Watkins has advised Mr. Zhong Ming, founder and chairman of Kangji Medical Holdings (Kangji Medical), on a proposal to take Kangji Medical private. A consortium led by Mr. Zhong, TPG, TPG NewQuest, and QIA valued the company at approximately US$1.4 billion.

Kangji Medical is a leading medical device platform specializing in minimally invasive surgery in China. It was founded in 2004 with headquarters at Hangzhou, Zhejiang Province, China. It was listed on the mainboard of the Stock Exchange of Hong Kong in June 2020.

The Latham team was led by Hong Kong partners Terris Tang and Zhonghua (Stephen) Shi, with counsel Ruonan Duan, and associates Haifan (Mark) Hu and Gladys H.C. Ma. Advice was also provided on tax matters by San Francisco partner Kirt Switzer.

Endnotes

    Contacts

    Tang, Terris

    Terris Tang

    Hong Kong
    terris.tang@lw.com +852.2912.2719
    Shi, Zhonghua (Stephen)

    Zhonghua (Stephen) Shi

    Hong Kong
    stephen.shi@lw.com +852.2912.2726